Eli Lilly CEO explains how AI will impact the pharmaceutical industry
2 sourcesUpdated Oct 24, 20261 min read
Sponsored
Sponsored
How it spread
What each side asserts, disputes — or leaves out entirely.
Whose framing of this story rings truest to you?
Cutting research costs with AI sounds fine but only if it actually lowers what we pay at the pharmacy.
I hope the focus stays on safety rather than rushing approvals just because AI flags a candidate molecule.
It's promising that Eli Lilly is using AI to speed up drug discovery. That could mean better treatments reaching patients faster.